Pulike Biological Engineering, Inc. (SHA:603566)

SHA:603566 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,077	1,034	1,243	1,217	1,088	917.41
Other Revenue	8.69	8.69	10.11	13.06	11.03	11.1
Revenue	1,086	1,043	1,253	1,230	1,099	928.51
Revenue Growth (YoY)	-8.09%	-16.77%	1.84%	11.97%	18.32%	40.01%
Cost of Revenue	434.07	405.63	488.4	459.74	379.95	331.25
Gross Profit	651.62	636.93	764.3	770.33	718.62	597.26
Selling, General & Admin	397.01	413.65	450.03	473.74	391.87	292.77
Research & Development	106.5	106.05	101.1	92.62	85.57	114.84
Other Operating Expenses	17.06	16.6	14.62	12.77	11.29	10.34
Operating Expenses	515.16	531.02	593.41	594.47	496.51	427.25
Operating Income	136.46	105.91	170.89	175.86	222.11	170.02
Interest Expense	-0.08	-0.08	-0.92	-0.86	-	-
Interest & Investment Income	3.82	4.8	21.79	10.09	2.5	15.03
Currency Exchange Gain (Loss)	0.19	0.19	0.22	0.58	-0.22	-0.02
Other Non Operating Income (Expenses)	-0.59	-0.78	-0.73	-0.65	-0.56	0.1
EBT Excluding Unusual Items	139.79	110.03	191.25	185.02	223.84	185.12
Gain (Loss) on Sale of Investments	-8.9	-9.97	-17.69	-25.57	20.39	24.32
Gain (Loss) on Sale of Assets	-12.33	-12.27	-0.6	-0.54	-3.34	0.29
Asset Writedown	-0.63	-1	-0.03	-	-	-
Other Unusual Items	11.98	11.98	21.68	18.81	43.28	50.28
Pretax Income	129.91	98.76	194.61	177.72	284.18	260
Income Tax Expense	11.5	5.96	20.1	9.9	40.04	32.26
Net Income	118.41	92.81	174.52	167.82	244.14	227.74
Net Income to Common	118.41	92.81	174.52	167.82	244.14	227.74
Net Income Growth	-14.06%	-46.82%	3.99%	-31.26%	7.20%	108.47%
Shares Outstanding (Basic)	341	344	349	323	313	316
Shares Outstanding (Diluted)	341	344	349	323	313	316
Shares Change (YoY)	-2.58%	-1.52%	8.15%	3.11%	-1.05%	-1.56%
EPS (Basic)	0.35	0.27	0.50	0.52	0.78	0.72
EPS (Diluted)	0.35	0.27	0.50	0.52	0.78	0.72
EPS Growth	-11.79%	-46.00%	-3.85%	-33.33%	8.33%	111.77%
Free Cash Flow	247.44	147.73	-22.2	-128.8	-105.01	84.69
Free Cash Flow Per Share	0.73	0.43	-0.06	-0.40	-0.34	0.27
Dividend Per Share	0.400	0.400	0.700	0.350	0.200	0.500
Dividend Growth	-42.86%	-42.86%	100.00%	75.00%	-60.00%	150.00%
Gross Margin	60.02%	61.09%	61.01%	62.63%	65.41%	64.33%
Operating Margin	12.57%	10.16%	13.64%	14.30%	20.22%	18.31%
Profit Margin	10.91%	8.90%	13.93%	13.64%	22.22%	24.53%
Free Cash Flow Margin	22.79%	14.17%	-1.77%	-10.47%	-9.56%	9.12%
EBITDA	262.58	225.17	262.7	249.8	281.42	221.07
EBITDA Margin	24.19%	21.60%	20.97%	20.31%	25.62%	23.81%
D&A For EBITDA	126.12	119.26	91.81	73.93	59.31	51.05
EBIT	136.46	105.91	170.89	175.86	222.11	170.02
EBIT Margin	12.57%	10.16%	13.64%	14.30%	20.22%	18.31%
Effective Tax Rate	8.86%	6.03%	10.33%	5.57%	14.09%	12.41%
Revenue as Reported	1,086	1,043	1,253	1,230	1,099	928.51
Advertising Expenses	-	10.27	5.54	7.62	7.54	6.19

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.